Unknown

Dataset Information

0

Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome.


ABSTRACT: Multicatalytic endopeptidase complex-like-1 (?2i), low molecular mass polypeptide (LMP) 2 (?1i) and LMP7 (?5i) are the proteolytically active subunits of the immunoproteasome, a special type of proteasome mainly expressed in haematopoietic cells. Targeting LMP7 has been shown to be therapeutically effective in preclinical models of autoimmune diseases. In this study, we investigated the selectivity and biological activity of LU-005i, a recently described inhibitor of the immunoproteasome.The specificity of LU-005i and other immunoproteasome-selective inhibitors was characterized using fluorogenic peptide substrates. The effect of proteasome inhibition on cytokine release was investigated in endotoxin-stimulated mouse splenocytes or human peripheral blood mononuclear cells (PBMCs). The effect of proteasome inhibition on inflammatory bowel disease in the dextran sulfate sodium (DSS)-induced colitis model was assessed by measuring weight loss and colon length.LU-005i is the first human and mouse immunoproteasome-selective inhibitor that targets all three proteolytically active immunoproteasome subunits. LU-005i inhibited cytokine secretion from endotoxin-stimulated mouse splenocytes or human PBMCs. Furthermore, differentiation of naïve T helper cells to T helper 17 cells was impaired in the presence of LU-005i. Additionally, LU-005i ameliorated DSS-induced colitis.This study with a novel pan-immunoproteasome inhibitor substantiates that the immunoproteasome is a promising drug target for the treatment of inflammatory diseases and that exclusive inhibition of LMP7 is not necessary for therapeutic effectiveness. Our results will promote the design of new generations of immunoproteasome inhibitors with optimal therapeutic efficacy for clinical use in the treatment of autoimmunity and cancer.

SUBMITTER: Basler M 

PROVIDER: S-EPMC5740239 | BioStudies | 2018-01-01T00:00:00Z

SECONDARY ACCESSION(S): 001i

REPOSITORIES: biostudies

Similar Datasets

2020-04-14 | S-SCDT-EMBOR-2018-46512V1 | BioStudies
1000-01-01 | S-EPMC4726078 | BioStudies
2010-07-07 | GSE18163 | GEO
2010-07-06 | E-GEOD-18163 | ArrayExpress
2016-01-01 | S-EPMC4987736 | BioStudies
1000-01-01 | S-EPMC4027612 | BioStudies
2016-06-29 | E-GEOD-72000 | ArrayExpress
2010-01-01 | S-EPMC2909641 | BioStudies
1000-01-01 | S-EPMC6045542 | BioStudies
1000-01-01 | S-EPMC5584149 | BioStudies